114 related articles for article (PubMed ID: 6308148)
1. (3,4-Dihydroxyphenylimino)-2-imidazoline (DPI) and its action at noradrenergic and dopaminergic receptors in the nucleus accumbens of rats: mesolimbic catecholamine receptors and hyperactivity.
Cools AR; Oosterloo SK
J Neural Transm Suppl; 1983; 18():181-8. PubMed ID: 6308148
[TBL] [Abstract][Full Text] [Related]
2. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
Ikeda H; Moribe S; Sato M; Kotani A; Koshikawa N; Cools AR
Eur J Pharmacol; 2007 Jan; 554(2-3):175-82. PubMed ID: 17113067
[TBL] [Abstract][Full Text] [Related]
3. Presence of a particular subpopulation of dopamine receptors within the septal nuclei: a behavioural study on cats.
Megens AA; Cools AR
Eur J Pharmacol; 1981 May; 71(2-3):247-58. PubMed ID: 6265235
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism.
van Oene JC; Houwing HA; Horn AS
Eur J Pharmacol; 1982 Jun; 81(1):75-87. PubMed ID: 6126370
[TBL] [Abstract][Full Text] [Related]
5. Ergometrine and its biphasic action at dopaminergic receptors in the nucleus accumbens of rats.
Cools AR
Pharmacology; 1978; 16 Suppl 1():93-8. PubMed ID: 643907
[TBL] [Abstract][Full Text] [Related]
6. Agonistic actions of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on alpha-adrenoceptors and dopamine receptors.
Woodman OL; Medgett IC; Lang WJ; Rand MJ
Eur J Pharmacol; 1981 Oct; 75(1):11-9. PubMed ID: 6119208
[TBL] [Abstract][Full Text] [Related]
7. Modulation of feeding and drinking behaviour by catecholamines injected into nucleus accumbens in rats.
Pal P; Raj SS; Mohan M; Pal GK
Indian J Physiol Pharmacol; 2000 Jan; 44(1):24-32. PubMed ID: 10919092
[TBL] [Abstract][Full Text] [Related]
8. Role of the nucleus accumbens in social memory in rats.
Ploeger GE; Willemen AP; Cools AR
Brain Res Bull; 1991 Jan; 26(1):23-7. PubMed ID: 1673081
[TBL] [Abstract][Full Text] [Related]
9. A demonstration of the ability of apomorphine to act on dopamine receptors on nerve terminals in the nucleus accumbens to reduce locomotor hyperactivity [proceedings].
Costall B; Hui SC; Naylor RJ
Br J Pharmacol; 1979 Nov; 67(3):475P-476P. PubMed ID: 497587
[No Abstract] [Full Text] [Related]
10. Effects of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on prejunctional alpha-adrenoceptors and prejunctional dopamine receptors in the rabbit ear artery.
Medgett IC
Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(2):141-4. PubMed ID: 6136918
[TBL] [Abstract][Full Text] [Related]
11. Activation of accumbal and striatal dopamine autoreceptors by some ergoline derivatives.
Gundlach AL; Christie MJ; Beart PM
Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):149-52. PubMed ID: 3992029
[TBL] [Abstract][Full Text] [Related]
12. Mesolimbic noradrenaline: specificity, stability and dose-dependency of individual-specific responses to mesolimbic injections of alpha-noradrenergic agonists.
Cools AR; Ellenbroek B; van den Bos R; Gelissen M
Behav Brain Res; 1987 Jul; 25(1):49-61. PubMed ID: 3620086
[TBL] [Abstract][Full Text] [Related]
13. DPI, a supposed selective agonist of inhibitory dopamine receptors, strongly increases rat diuresis through alpha-adrenergic receptor activation.
Baggio G; Ferrari F
Life Sci; 1981 Mar; 28(13):1449-56. PubMed ID: 6113526
[No Abstract] [Full Text] [Related]
14. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens.
Morgenstern R; Fink H
Biomed Biochim Acta; 1985; 44(10):1517-22. PubMed ID: 4084255
[TBL] [Abstract][Full Text] [Related]
15. Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of the rat.
Pijnenburg AJ; Honig WM; Boudier HA; Cools AR; Van der Heyden JA; Van Rossum JM
Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):103-15. PubMed ID: 984962
[TBL] [Abstract][Full Text] [Related]
16. Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens.
Cools AR
Psychopharmacology (Berl); 1986; 88(4):451-9. PubMed ID: 3085132
[TBL] [Abstract][Full Text] [Related]
17. Disruption of G(i/o) protein signaling in the nucleus accumbens results in a D1 dopamine receptor-mediated hyperactivity.
Schroeder JA; Hummel M; Unterwald EM
Pharmacol Biochem Behav; 2004 Sep; 79(1):93-9. PubMed ID: 15388288
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic potentiation of neuroleptic effects in the nucleus accumbens.
Vance MA; Blumberg JB
Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):345-8. PubMed ID: 6136070
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a role of the shell of the nucleus accumbens in oral behavior of freely moving rats.
Prinssen EP; Balestra W; Bemelmans FF; Cools AR
J Neurosci; 1994 Mar; 14(3 Pt 2):1555-62. PubMed ID: 7907364
[TBL] [Abstract][Full Text] [Related]
20. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
